Fabrizio Citarella

Università Campus Bio-Medico — Italy

Medicine · Health Sciences

22h-index1.6kcitations94works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(52), Cancer Immunotherapy and Biomarkers(35), Lung Cancer Research Studies(21), Lung Cancer Diagnosis and Treatment(15), Colorectal Cancer Treatments and Studies(13)

Publications94 total

Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional − prospective study to inform referral for germline testing
Lung Cancer·2026Open Access
Overcoming Immunotherapy Resistance in Small-Cell Lung Cancer
Biology·2026Open Access
Braf-mutant metastatic non–small-cell lung cancer: Real world data from the Italian biomarker atlas database
European Journal of Cancer·2025Open Access
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature Review
Clinical Lung Cancer·2025Open Access
1037 Non-infectious sarcoid-like inflammatory granulomatous conditions (NSIGC) associated with Immune checkpoint inhibitors (ICIs) for cancer: updated results from the international ICARUS consortium
Regular and Young Investigator Award Abstracts·2025Open Access
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Lung Cancer·2025Open Access
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
The Lancet Oncology·2025· 3 cited
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
Lung Cancer·2025Open Access
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
Nature Communications·2025· 4 citedOpen Access
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis
Cancers·2025Open Access
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
Lung Cancer Targets and Therapy·2025· 2 citedOpen Access
Rechallenge with first-generation RET inhibitors in <i>RET</i> -rearranged NSCLC pre-treated with selpercatinib or pralsetinib: Results from the RET MAP registry.
Journal of Clinical Oncology·2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAF <sup>V600E</sup> -mutated metastatic non-small cell lung cancer: The FRONT-BRAF study.
Journal of Clinical Oncology·2025· 2 cited
Integrated Molecular and Clinical Characterization of Pulmonary Large Cell Neuroendocrine Carcinoma
2025Open Access
The identification and prediction of lung adenocarcinoma prognosis using a novel gene signature associated with DNA replication
Translational Cancer Research·2025· 3 citedOpen Access
Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database
SSRN Electronic Journal·2025Open Access
Braf-Mutant Metastatic Non–Small-Cell Lung Cancer: Real World Data from the Italian Biomarker Atlas Database
SSRN Electronic Journal·2025Open Access
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer
JAMA Oncology·2024· 56 citedOpen Access
28P Circulating biomarkers in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Immuno-Oncology Technology·2024Open Access
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)
Regular and Young Investigator Award Abstracts·2024Open Access
page 1 of 5Next →

Frequent Co-authors

Alessio Cortellini(25), Marco Russano(24), Daniele Santini(21), Giuseppe Tonini(18), Raffaele Giusti(18), Rita Chiari(18), Diego Cortinovis(17), Bruno Vincenzi(16), Marco Filetti(16), Emilio Bria(15), Rossana Berardi(15), Carlo Genova(15), Federica Zoratto(15), Francesco Grossi(14), Alain Gelibter(14), Luca Cantini(14), Corrado Ficorella(14), Giampiero Porzio(14), Marcello Tiseo(14), Michele De Tursi(14)